Links to all GeneRIF Items | 3135 |
PubMed (Gene Name) | Literature evidence |
|---|---|
| 17673327 (HLA-G) | These results indicate that the expression of HLA-G is a characteristic feature of non-small cell lung cancer, and they suggest that immunostaining by anti-HLA-G antibodies may be a potentially useful prognostic indicator. |
| 19602033 (HLA-G) | Both lesion HLA-G expression and plasma sHLA-G in non-small-cell lung cancer is related to the disease stage and can exert immunosuppression to the natural killer cell cytolysis. |
| 21726203 (HLA-G) | plasma sHLA-G may be differentially expressed in colorectal, gastric, esophageal and lung cancer |
| 25689063 (HLA-G) | Data show that tumour cell human leucocyte antigen sHLA-G was predominately expressed in lung adenocarcinoma, which could be a useful biomarker to discriminate adenocarcinoma from squamous cell carcinoma in non-small-cell lung cancer (NSCLC) patients. |
| 26939901 (HLA-G) | our results indicate that the ILT4-HLA-G interaction might play an important role in Non-small cell lung cancer progression |
| 27517300 (HLA-G) | Human Leukocyte Antigen G Polymorphism and high expression is associated with increased Risk of Non-Small-Cell lung cancer. |